GeneDx (WGS) Operating Margin (2020 - 2026)
GeneDx (WGS) operating margin from Sep 30, 2020 to Mar 31, 2026. The current GeneDx (WGS) operating margin is -56.21%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of GeneDx (WGS)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | -3.06% | -59.74% |
| 2024 | -7.60% | -91.48% |
| 2023 | -89.15% | -68.66% |
| 2022 | -284.48% | +35.31% |
| 2021 | -210.25% | +55.80% |
| 2020 | -134.95% | -6.97% |
| 2020 | -145.07% | +27.82% |
| 2020 | -113.49% | +97.81% |
| 2020 | -57.37% | +270.10% |
| 2019 | -15.50% | N/A |
Comparison GeneDx (WGS) operating margin with competitors
GeneDx (WGS) operating margin is -56.21%.
| Ticker | Name | Operating Margin | Upside |
|---|---|---|---|
| IDXX | Idexx Laboratories Inc | 31.78% | -156.54% |
| SHC | Sotera Health Company | 28.16% | -150.10% |
| MTD | Mettler-Toledo International Inc | 26.00% | -146.26% |
| DHR | Danaher Corp | 22.58% | -140.17% |
| QGEN | Qiagen NV | 22.29% | -139.66% |
| MEDP | Medpace Holdings Inc | 20.03% | -135.64% |
| A | Agilent Technologies Inc | 19.63% | -134.93% |
| ILMN | Illumina Inc | 19.16% | -134.09% |
| TMO | Thermo Fisher Scientific Inc | 16.93% | -130.12% |
| BLLN | Billiontoone Inc - Class A | 16.45% | -129.27% |
| VCYT | Veracyte Inc | 16.28% | -128.97% |
| DGX | Quest Diagnostics Inc | 13.78% | -124.52% |
| IQV | IQVIA Holdings Inc | 12.38% | -122.03% |
| CRL | Charles River Laboratories International Inc | 12.04% | -121.42% |
| LH | Laboratory Corp Of America Holdings | 10.76% | -119.14% |
| RVTY | Revvity Inc | 10.67% | -118.98% |
| ICLR | Icon Plc | 5.37% | -109.55% |
| CDNA | Caredx Inc | 1.02% | -101.81% |